These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2990662)

  • 1. Clinical, serologic, and immunologic effects of human leukocyte interferon in HBsAg-positive primary hepatocellular carcinoma.
    Nair PV; Tong MJ; Kempf R; Co R; Lee SD; Venturi CL
    Cancer; 1985 Sep; 56(5):1018-22. PubMed ID: 2990662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus infection and primary hepatocellular carcinoma.
    Tabor E; Gerety RJ; Vogel CL; Bayley AC; Anthony PP; Chan CH; Barker LF
    J Natl Cancer Inst; 1977 May; 58(5):1197-200. PubMed ID: 192895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hepatocellular carcinoma in Australia: Aetiological considerations.
    McCaughan G; Parsons C; Gallagher ND
    Med J Aust; 1979 Apr; 1(8):304-6. PubMed ID: 221795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid.
    Actis GC; Ponzetto A; D'Urso N; Saracco G; Crepaldi T; Bellone G; Catucci LM; Zarcone D; Verme G
    Liver; 1991 Apr; 11(2):106-13. PubMed ID: 1646927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
    Khin LW; Teo CJ; Guan R
    Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)].
    Volc-Platzer B; Hanak H; Weiss W; Denk H
    Wien Klin Wochenschr; 1982 Feb; 94(4):108-14. PubMed ID: 6281995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
    Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
    J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
    Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
    Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons.
    Yamashita Y; Koike K; Takaoki M; Matsuda S
    Microbiol Immunol; 1988; 32(11):1119-26. PubMed ID: 2464737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 6-year-old boy having hepatocellular carcinoma associated with hepatitis B surface antigenemia.
    Shimoda T; Uchida T; Miyata H; Abe K; Ariga H; Shikata T; Fujii Y
    Am J Clin Pathol; 1980 Dec; 74(6):827-31. PubMed ID: 6255792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
    Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
    Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case/control study of hepatitis B virus serologic markers in Senegalese patients suffering from primary hepatocellular carcinoma.
    Coursaget P; Maupas P; Goudeau A; Chiron JP; Raynaud B; Drucker J; Barin F; Denis F; Diop Mar I; Diop B
    Prog Med Virol; 1981; 27():49-59. PubMed ID: 6262871
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma and the hepatitis B virus: a study of British patients.
    Dunk AA; Spiliadis H; Sherlock S; Fowler MJ; Monjardino JP; Scheuer PJ; Karayiannis P; Thomas HC
    Q J Med; 1987 Feb; 62(238):109-16. PubMed ID: 2821569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum alphafetoprotein in hepatocellular carcinoma.
    Chen DS; Sung JL
    Cancer; 1977 Aug; 40(2):779-83. PubMed ID: 70268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of hepatitis B virus with chronic liver diseases and hepatocellular carcinoma.
    Pati S; Patnaik S; Chawda S; Nanda BK
    Indian J Pathol Microbiol; 1989 Apr; 32(2):122-4. PubMed ID: 2553594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus e antigen and primary hepatocellular carcinoma.
    Lin TM; Chen CJ; Lu SN; Chang AS; Chang YC; Hsu ST; Liu JY; Liaw YF; Chang WY
    Anticancer Res; 1991; 11(6):2063-5. PubMed ID: 1663719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia.
    Swenson PD; Escobar MR; Silverman JF
    Acta Biol Acad Sci Hung; 1980; 31(1-3):321-8. PubMed ID: 6261496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.